Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis
Roviello, Giandomenico
•
2017
Periodico
EUROPEAN UROLOGY
Abstract
The aim of this letter is to focus on the survival of patients treated with nivolumab and cabozantinib according to prior first-line TKI. We used data from CheckMate 025 and METEOR for a subsequent subgroup analysis
DOI
WOS
Archivio
Diritti
open access
license:digital rights management non definito
license:creative commons
license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/
FVG url
Soggetti